Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.

Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Sow PS, Ehrenkranz P, Ford D, Mugurungi O, Apollo T, Murungu J, Bangsberg DR, Revill P.

PLoS One. 2016 Dec 15;11(12):e0167654. doi: 10.1371/journal.pone.0167654. eCollection 2016.

2.

Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time.

Livelli A, Orofino GC, Calcagno A, Farenga M, Penoncelli D, Guastavigna M, Carosella S, Caramello P, Pia L.

Front Behav Neurosci. 2015 Nov 16;9:306. doi: 10.3389/fnbeh.2015.00306. eCollection 2015.

3.

Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.

Moore DJ, Poquette A, Casaletto KB, Gouaux B, Montoya JL, Posada C, Rooney AS, Badiee J, Deutsch R, Letendre SL, Depp CA, Grant I, Atkinson JH; HIV Neurobehavioral Research Program (HNRP) Group.

AIDS Behav. 2015 Mar;19(3):459-71. doi: 10.1007/s10461-014-0971-0.

4.

Medication adherence challenges among HIV positive substance abusers: the role of food and housing insecurity.

Surratt HL, O'Grady CL, Levi-Minzi MA, Kurtz SP.

AIDS Care. 2015;27(3):307-14. doi: 10.1080/09540121.2014.967656. Epub 2014 Oct 14.

5.

Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study.

Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP.

J Assoc Nurses AIDS Care. 2014 Sep-Oct;25(5):405-13. doi: 10.1016/j.jana.2013.12.002. Epub 2014 Feb 6.

6.

Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.

Montoya JL, Umlauf A, Abramson I, Badiee J, Woods SP, Atkinson JH, Grant I, Moore DJ; TMARC Group.

J Affect Disord. 2013 Nov;151(2):728-37. doi: 10.1016/j.jad.2013.07.036. Epub 2013 Aug 16.

7.

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.

Crum-Cianflone NF, Moore DJ, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR.

Neurology. 2013 Jan 22;80(4):371-9. doi: 10.1212/WNL.0b013e31827f0776. Epub 2013 Jan 9.

8.

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):282-92. doi: 10.1097/QAI.0b013e31827ed678.

9.

Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting.

Thirumurthy H, Siripong N, Vreeman RC, Pop-Eleches C, Habyarimana JP, Sidle JE, Siika AM, Bangsberg DR.

AIDS. 2012 Nov 28;26(18):2399-403. doi: 10.1097/QAD.0b013e328359aa68.

10.

Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.

Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK.

Clin Neuropsychol. 2012;26(6):894-908. doi: 10.1080/13854046.2012.694479. Epub 2012 Jun 18.

11.

HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.

Moore DJ, Posada C, Parikh M, Arce M, Vaida F, Riggs PK, Gouaux B, Ellis RJ, Letendre SL, Grant I, Atkinson JH; HIV Neurobahavioral Research Program (HNRP).

AIDS Behav. 2012 Nov;16(8):2257-66. doi: 10.1007/s10461-011-0072-2.

12.

Antiretroviral adherence and the nature of HIV-associated verbal memory impairment.

Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):324-31. doi: 10.1176/appi.neuropsych.23.3.324.

13.

Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men.

Hightow-Weidman LB, Jones K, Phillips G 2nd, Wohl A, Giordano TP; YMSM of Color SPNS Initiative Study Group.

AIDS Patient Care STDS. 2011 Aug;25 Suppl 1:S9-14. doi: 10.1089/apc.2011.9881. Epub 2011 Jun 28.

14.

Longitudinal change in cognitive function and medication adherence in HIV-infected adults.

Becker BW, Thames AD, Woo E, Castellon SA, Hinkin CH.

AIDS Behav. 2011 Nov;15(8):1888-94. doi: 10.1007/s10461-011-9924-z.

15.

Antiretroviral therapy: a promising HIV prevention strategy?

El-Sadr WM, Affrunti M, Gamble T, Zerbe A.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S116-21. doi: 10.1097/QAI.0b013e3181fbca6e.

16.

Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Meade CS, Conn NA, Skalski LM, Safren SA.

J Behav Med. 2011 Apr;34(2):128-38. doi: 10.1007/s10865-010-9293-5. Epub 2010 Sep 21.

17.

Assessing medication adherence of perinatally HIV-infected children using caregiver interviews.

Allison SM, Koenig LJ, Marhefka SL, Carter RJ, Abrams EJ, Bulterys M, Tepper V, Palumbo PE, Bachanas PJ, Farley JJ.

J Assoc Nurses AIDS Care. 2010 Nov-Dec;21(6):478-88. doi: 10.1016/j.jana.2010.02.006. Epub 2010 May 7.

18.

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA.

AIDS Patient Care STDS. 2009 Jun;23(6):455-62. doi: 10.1089/apc.2008.0181.

19.

Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Woods SP, Moore DJ, Weber E, Grant I.

Neuropsychol Rev. 2009 Jun;19(2):152-68. doi: 10.1007/s11065-009-9102-5. Epub 2009 May 22. Review.

20.

Variable patterns of neuropsychological performance in HIV-1 infection.

Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK; HNRC Group.

J Clin Exp Neuropsychol. 2008 Aug;30(6):613-26. doi: 10.1080/13803390701565225. Epub 2008 Mar 4.

Supplemental Content

Support Center